<unk>  is an antineoplastic agent that is FDA approved for the treatment of advanced ovarian carcinoma. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include alopecia, hypocalcemia, hypokalemia, hypomagnesemia, hyponatremia, abdominal pain, diarrhea, nausea, vomiting, anemia, leukopenia, neutropenia, thrombocytopenia, pain, and elevation of alkaline phosphatase, AST, BUN, and creatinine.
Carboplatin
Ifosfamide
Mafosfamide
Semustine
Zorubicin
Etoposide 
Satraplatin
Lomustine